ENT & Allergy Report – Q1 2021 Acquisition Activity and Outlook
Private Equity Interest in ENT & Allergy Practices Accelerates. Expect Increasing Opportunity for Large Practice Sellers.
The first quarter of 2021 delivered five reported ENT practice acquisitions marking the most active three-month M&A period we have seen in the specialty. Notably, Audax Private Equity formally named its portfolio company “Elevate ENT” and expanded into Texas with the major acquisition of Texas ENT Specialists. While the next quarter may not produce as many deals, activity should remain high throughout this year.White Paper: Private Equity Investment in Physician Owned Specialty Practices
The FOCUS healthcare team represents medical practices and ancillary businesses in specialties where private equity-backed consolidation is occurring. We track activity in key verticals and maintain strong relationships with private equity firms and their portfolio companies.
Cruinn Diagnostics Limited has been acquired by MML Capital Ireland
Kahla Cooper2024-02-14T12:35:08+00:00Clinart, Inc. has been acquired by Clinical Trial & Consulting (CTI)
Kahla Cooper2024-02-14T13:38:44+00:00Washington, DC, (August 31, 2020) – FOCUS Investment Banking (“FOCUS”), ...